D-0507-2019 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0507-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 31, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out of specification results observed for high dissolution. The recall status is terminated (terminated Feb 14, 2023). Affected quantity: 10,656 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 27, 2019
Initiation Date
Jan 31, 2019
Termination Date
Feb 14, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,656 bottles

Product description

Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01

Reason for recall

Failed Dissolution Specifications: Out of specification results observed for high dissolution.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: C802676, Exp 03/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0507-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0507-2019. Report a data issue: hello@regdatalab.com.